Toll-like receptor 3 expression inhibits cell invasion and migration and predicts a favorable prognosis in neuroblastoma

Cancer Letters

Volumn 336, Issue 2, 2013, Pages 338-346

  Hsu, Wen Ming ^a   Huang, Chao Cheng ^b   Wu, Pei Yi ^c   Lee, Hsinyu ^c   Huang, Min Chuan ^c   Tai, Ming Hong ^d   Chuang, Jiin Haur ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Migration; Neuroblastoma; Poly(I:C); Prognosis; Toll like receptor 3

Indexed keywords

F ACTIN; MESSENGER RNA; NEUROMODULIN; POLYINOSINIC POLYCYTIDYLIC ACID; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 3;

ARTICLE; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CHILD; CONTROLLED STUDY; FEMALE; FILOPODIUM; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ACTINS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CHILD; CHILD, PRESCHOOL; FEMALE; GAP-43 PROTEIN; GENE EXPRESSION; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEUROBLASTOMA; POLY I-C; PROGNOSIS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 84879783063     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.03.024     Document Type: Article

References (35)

1. Maris J.M. Recent advances in neuroblastoma. New Engl. J. Med. 2010, 362:2202-2211.
2. Maris J.M., Hogarty M.D., Bagatell R., Cohn S.L. Neuroblastoma. Lancet 2007, 369:2106-2120.
3. Hsu W.M., Hsieh F.J., Jeng Y.M., Kuo M.L., Tsao P.N., Lee H., Lin M.T., Lai H.S., Chen C.N., Lai D.M., Chen W.J. GRP78 expression correlates with histologic differentiation and favorable prognosis in neuroblastic tumors. Int. J. Cancer 2005, 113:920-927.
4. Hsu W.M., Hsieh F.J., Jeng Y.M., Kuo M.L., Chen C.N., Lai D.M., Hsieh L.J., Wang B.T., Tsao P.N., Lee H., Lin M.T., Lai H.S., Chen W.J. Calreticulin expression in neuroblastoma - a novel independent prognostic factor. Ann. Oncol. 2005, 16:314-321.
5. 1 integrin signaling in neuroblastoma. Am. J. Pathol. 2011, 179:1394-1404.
6. Rose D., Zhu X., Kose H., Hoang B., Cho J., Chiba A. Toll, a muscle cell surface molecule, locally inhibits synaptic initiation of the RP3 motoneuron growth cone in Drosophila. Development 1997, 124:1561-1571.
7. Salaun B., Coste I., Rissoan M.C., Lebecque S.J., Renno T. TLR3 can directly trigger apoptosis in human cancer cells. J. Immunol. 2006, 176:4894-4901.
8. Khvalevsky E., Rivkin L., Rachmilewitz J., Galun E., Giladi H. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. J. Cell Biochem. 2007, 100:1301-1312.
9. Salaun B., Lebecque S., Matikainen S., Rimoldi D., Romero P. Toll-like receptor 3 expressed by melanoma cells as a target for therapy?. Clin. Cancer Res. 2007, 13:4565-4574.
10. Morikawa T., Sugiyama A., Kume H., Ota S., Kashima T., Tomita K., Kitamura T., Kodama T., Fukayama M., Aburatani H. Identification of toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma. Clin. Cancer Res. 2007, 13:5703-5709.
11. Salaun B., Zitvogel L., Asselin-Paturel C., Morel Y., Chemin K., Dubois C., Massacrier C., Conforti R., Chenard M.P., Sabourin J.C., Goubar A., Lebecque S., Pierres M., Rimoldi D., Romero P., Andre F. TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer. Cancer Res. 2011, 71:1607-1614.
12. Chuang J.H., Chuang H.C., Huang C.C., Wu C.L., Du Y.Y., Kung M.L., Chen C.H., Chen S.C., Tai M.H. Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells. J. Biomed. Sci. 2011, 18:65.
13. Chuang J.H., Lin T.K., Tai M.H., Liou C.W., Huang S.T., Wu C.L., Lin H.Y., Wang P.W. Preferential involvement of mitochondria in toll-like receptor 3 agonist-induced neuroblastoma cell apoptosis, but not in inhibition of cell growth. Apoptosis 2011, 17:335-348.
14. Chuang H.C., Huang C.C., Chien C.Y., Chuang J.H. Toll-like receptor 3-mediated tumor invasion in head and neck cancer. Oral Oncol. 2012, 48:226-232.
15. Shimada H., Ambros I.M., Dehner L.P., Hata J., Joshi V.V., Roald B. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the international neuroblastoma pathology committee. Cancer 1999, 86:349-363.
16. Peuchmaur M., d'Amore E.S., Joshi V.V., Hata J., Roald B., Dehner L.P., Gerbing R.B., Stram D.O., Lukens J.N., Matthay K.K., Shimada H. Revision of the international neuroblastoma pathology classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer 2003, 98:2274-2281.
17. Brodeur G.M., Pritchard J., Berthold F., Brodeur G.M., Pritchard J., Berthold F., Carlsen N.L., Castel V., Castelberry R.P., De Bernardi B., Evans A.E., Favrot M., Hedborg F., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J. Clin. Oncol. 1993, 11:1466-1477.
18. Tajiri T., Shono K., Fujii Y., Noguchi S., Kinoshita Y., Tsuneyoshi M., Suita S. Highly sensitive analysis for N-myc amplification in neuroblastoma based on fluorescence in situ hybridization. J. Pediatr. Surg. 1999, 34:1615-1619.
19. Köpf I., Hanson C., Delle U., Verbiené I., Weimarck A. A rapid and simplified technique for analysis of archival formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization (FISH). Anticancer Res. 1996, 16:2533-2536.
20. Castleberry R.P. Neuroblastoma. Eur. J. Cancer 1997, 33:1430-1438.
21. Nürnberg A., Kitzing T., Grosse R. Nucleating actin for invasion. Nat. Rev. Cancer 2011, 11:177-187.
22. Wicki A., Lehembre F., Wick N., Hantusch B., Kerjaschki D., Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006, 9:261-272.
23. Wu M.H., Hong T.M., Cheng H.W., Pan S.H., Liang Y.R., Hong H.C., Chiang W.F., Wong T.Y., Shieh D.B., Shiau A.L., Jin Y.T., Chen Y.L. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol. Cancer Res. 2009, 7:311-318.
24. Shea T.B., Perrone-Bizzozero N.I., Beermann M.L., Benowitz L.I. Phospholipid-mediated delivery of anti-GAP-43 antibodies into neuroblastoma cells prevents neuritogenesis. J. Neurosci. 1991, 11:1685-1690.
25. Morton A.J., Buss T.N. Accelerated differentiation in response to retinoic acid after retrovirally mediated gene transfer of GAP-43 into mouse neuroblastoma cells. Eur. J. Neurosci. 1992, 4:910-916.
26. Weber A., Kirejczyk Z., Besch R., Potthoff S., Leverkus M., Häcker G. Proapoptotic signalling through toll-like receptor-3 involves TRIF-dependent activation of caspase-8 and is under the control of inhibitor of apoptosis proteins in melanoma cells. Cell Death Differ. 2010, 17:942-951.
27. Park J.H., Jeon D.I., Yoon H.E., Kwon S.M., Kim S.A., Ahn S.G., Yoon J.H. Poly I:C inhibits cell proliferation and enhances the growth inhibitory effect of paclitaxel in oral squamous cell carcinoma. Acta Odontol. Scand. 2012, 70:241-245.
28. Guo Z., Chen L., Zhu Y., Zhang Y., He S., Qin J., Tang X., Zhou J., Wei Y. Double-stranded RNA-induced TLR3 activation inhibits angiogenesis and triggers apoptosis of human hepatocellular carcinoma cells. Oncol. Rep. 2012, 27:396-402.
29. Zimmer S., Steinmetz M., Asdonk T., Motz I., Coch C., Hartmann E., Barchet W., Wassmann S., Hartmann G., Nickenig G. Activation of endothelial toll-like receptor 3 impairs endothelial function. Circ. Res. 2011, 108:1358-1366.
30. Mukherjee A., Morosky S.A., Shen L., Weber C.R., Turner J.R., Kim K.S., Wang T., Coyne C.B. Retinoic acid-induced gene-1 (RIG-I) associates with the actin cytoskeleton via caspase activation and recruitment domain-dependent interactions. J. Biol. Chem. 2009, 284:6486-6494.
31. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998, 279:509-514.
32. Vitali R., Mancini C., Cesi V., Tanno B., Mancuso M., Bossi G., Zhang Y., Martinez R.V., Calabretta B., Dominici C., Raschellà G. Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical model. Clin. Cancer Res. 2008, 14:4622-4630.
33. Chountala M., Vakaloglou K.M., Zervas C.G. Parvin overexpression uncovers tissue-specific genetic pathways and disrupts F-actin to induce apoptosis in the developing epithelia in Drosophila. PLoS One 2012, 7:e47355.
34. Liu J., Zhang D., Luo W., Yu Y., Yu J., Li J., Zhang X., Zhang B., Chen J., Wu X.R., Rosas-Acosta G., Huang C. X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton. J. Biol. Chem. 2011, 286:15630-15640.
35. Boukhelifa M., Parast M.M., Valtschanoff J.G., LaMantia A.S., Meeker R.B., Otey C.A. A role for the cytoskeleton-associated protein palladin in neurite outgrowth. Mol. Biol. Cell 2001, 12:2721-2729.